CA-ONE-MIND
One Mind at Work, a leading mental health non-profit, Columbia University Mental Health + Work Design Lab, and corporate ethical standards measurement company Ethisphere, have formed a partnership to develop the Mental Health at Work Index™. The Index includes a standardized assessment of organizational programs and practices that support workforce mental health and an advice library that provides recommendations and resources to guide data-driven strategic improvement and innovations.
Accelerated by the COVID pandemic, around the world, the case for attending to mental health at work has never been greater. Research from the World Health Organization shows that 15 percent of working adults are affected by a mental health condition. The majority of workers expect their employers to support their mental health, and nearly all believe that employers could take actions that would make a real difference.
Recognizing the importance of providing a standardized tool to help organizations of all sizes and industries globally invest in sustainable and best-practice workplace mental health programs, a Founding Corporate Council of nine organizations have come together to help drive the development and adoption of the Mental Health at Work Index™. These founding members contribute their expertise and perspectives to ensure the practical value of the Index.
The founding members include:
- AXA, Asia & Africa, Founding Principal Partner
- Aon
- Bank of America
- Business Group on Health
- HCA Healthcare
- Jardine Matheson, MINDSET Care Limited (Singapore) and MINDSET Limited (Hong Kong)
- LifeWorks
- Prudential
- URAC
The Mental Health at Work Index™ will launch in early 2023 after the current beta testing phase is complete.
By completing The Mental Health at Work Index™, organizations can benchmark their programs and services, and use the personalized reports generated to help develop high-quality services and offerings that will translate into real impact.
Aligned with global guidance and standards, including International Organization for Standardization, Sustainability Accounting Standards Board, and the recently released World Health Organization guidelines, the Index guides leaders through an algorithm-driven library of resources and practical recommendations. These resources and evidence-based recommendations will provide business leaders with real data to inform strategic decision making about what has impact when it comes to mental health programs.
The Mental Health at Work Index “Three Ps Framework” assesses workforce mental health programs across the continuum of Protection, Promotion and Provision of care. The assessment dives deep into 10 organizational categories: mental health strategy, leadership, workforce engagement, communication, organizational culture, mental health training, work environment, mental health benefits, employment practices and monitoring and reporting.
Christina McCarthy, Executive Director of One Mind at Work, said, “The pandemic has highlighted the need for companies to invest in sustainable mental health strategies to support their employees. While approaches vary across different companies, the evidenced-based and technology-enabled Mental Health at Work Index sets a common standard, with best practice guidelines on the evaluation of workplace mental health initiatives that are vital in ensuring their success. It also helps equip companies with easy-to-access resources and practical recommendations to support mental health in the workplace in impactful, measurable ways.”
Dr. Kathleen M. Pike, Director of the Columbia University Mental Health + Work Design Lab said, “The data don’t lie. Mental health is impacting the workforce at every company and ignoring it is not an option. The Mental Health at Work Index is designed to empower leaders who recognize the needs of their workforce and are ready to step up on this critical issue. By partnering with One Mind and Ethisphere, we are tapping into a reservoir of expertise, creating evidence-based solutions to help leaders drive data-informed strategies that translate into better health and greater productivity for workers, while also shoring up recruitment and retention of talent.”
Craig Moss, EVP-Measurement of Ethisphere, said, “It is exciting to partner with Columbia University Mental Health + Work Design Lab and One Mind to bring our expertise in developing maturity assessments to the critical topic of mental health practices. Ultimately, companies need to create a culture that supports the mental health of their workforce. The Mental Health at Work Index will define what good looks like, create a maturity ladder and provide resources to make the improvement journey faster and more efficient. Under the leadership of AXA, the Founding Corporate Council has been a tremendous resource in helping us understand current practices, challenges, and opportunities for improvement.”
Gordon Watson, CEO of AXA Asia and Africa, said, “We are proud to be the founding principal partner of this pioneering Mental Health at Work Index, taking a leading role in collaborating with One Mind, Columbia University Mental Health + Work Design Lab, and Ethisphere. While companies are increasingly stepping up with expanded benefits to support the mental well-being of their people, more is needed when it comes to benchmarking progress made. The Index will address this critical gap by establishing a guided path for companies to achieve measurable progress in line with global standards. This is essential as companies continue to invest in and refine their mental health initiatives and ultimately deliver better mental health outcomes for employees.”
For more on the Mental Health at Work Index, visit mentalhealthindex.org, or email info@mentalhealthindex.org.
About One Mind and One Mind at Work
One Mind is a leading mental health non-profit that heals lives through science and advocacy. Around our collective vision of “Accelerating Brain Health for All”, One Mind is advancing a three-pronged program strategy of accelerating discoveries, scaling implementation, and transforming societal culture. Together, we are creating a world where all individuals facing brain health challenges can build healthy, productive lives. www.onemind.org
As an arm of One Mind, One Mind at Work is a global coalition of organizations committed to the development and implementation of a gold standard for workplace mental health and well-being. With most of the world’s population spending one-third of their adult lives at work, employers have a tremendous opportunity to improve quality of life for all people and play a critical role in driving mental health solutions. Leaving mental health needs unaddressed has costly results like higher absenteeism, increased liability, and lost productivity. One Mind at Work believes that a committed group of CEOs can transform the way we view and approach mental health, brain fitness, and well-being in the workplace. Today, there are nearly 150 One Mind at Work member organizations.
About The Columbia University Mental Health + Work Design Lab
The Mental Health + Work Design Lab, led by Dr. Kathleen M. Pike, provides thought leadership, content expertise, scientific research, and strategic guidance on advancing mental health at work. The Mental Health + Work Design Lab has a long history of collaborating closely with a wide range of organizations – both non-profit and for-profit, around the world – to address mental health at work. As part of the Columbia-World Health Organization Center for Global Mental Health, Dr. Pike and colleagues contributed scientific analysis and reporting to the forthcoming WHO Guidelines for Mental Health at Work. Providing targeted research reports, analytic models, survey instruments, and training programs, The Mental Health + Work Design Lab is committed to translating science into practice to improve mental health at work. The Mental Health + Work Design Lab streamlines the process of working with Columbia’s world-renowned researchers to bring scientific rigor to the pursuit of workforce mental health solutions.
About Ethisphere
Ethisphere is the global leader in defining and advancing the standards of ethical business practices that fuel corporate character, marketplace trust, and business success. Ethisphere has deep expertise in measuring and defining core ethics standards using data-driven insights that help companies enhance corporate character. Ethisphere honors superior achievement through its World’s Most Ethical Companies® recognition program, provides a community of industry experts with the Business Ethics Leadership Alliance (BELA), and showcases trends and best practices in ethics with Ethisphere Magazine. Ethisphere also helps to advance business performance through data-driven assessments, benchmarking, and guidance. For more information, visit https://ethisphere.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221004005194/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Volante Technologies Customers Successfully Navigate Critical Regulatory Deadlines for EU SEPA Instant and Global SWIFT Cross-Border Payments16.12.2025 10:00:00 CET | Press release
PaaS leader ensures seamless migrations and uninterrupted payment operations Volante Technologies, the global leader in Payments as a Service (PaaS), today announced it has successfully upgraded its clients to meet the latest SEPA Instant Payments Regulation (IPR) and SWIFT SRG 2025 mandate, which came into effect October 9th and November 22nd, 2025, respectively. This announcement follows the major FedISO upgrade in July, which shifted trillions of dollars in payments to the new ISO 20022 messaging format. SEPA IPR is a significant European milestone, requiring payments to be made within 10 seconds and at any time of day, throughout the year. Adoption was mandatory and Eurozone banks were compelled to meet strict deadlines, with January 9th, 2025 the deadline for receiving incoming instant payments and October 9th the deadline for sending outgoing instant payments. The latest deadline impacted more than 700 banks across Europe, with non-compliance penalties reaching at least 10% of an
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press release
TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 09:00:00 CET | Press release
RoslinCT is performing technology transfer and will support commercial manufacture of Omisirge® for an additional indication following successful clinical trialsOmisirge® now FDA-approved for an expanded patient population in hematologyRoslinCT continues to support and advance multiple cell therapy projects at its Hopkinton, MA facility Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support c
Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 07:00:00 CET | Press release
Leading encryption provider deepens commitment to European financial sector with rigorous new supplier qualification, building on existing UK & Ireland certification. Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It p
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 03:00:00 CET | Press release
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
